Lv45
654 积分 2022-07-30 加入
Obesity substantially impacts rheumatic and musculoskeletal diseases: time to act
1天前
已关闭
Antiobesity medications in rheumatology. Quo vadis?
1天前
已完结
Orforglipron for maintenance of body weight reduction: the double-blind, randomized phase 3b ATTAIN-MAINTAIN trial
2天前
已完结
Long COVID: a new word for naming fibromyalgia?
4天前
求助中
Current myositis clinical trials and tribulations
4天前
已完结
Should all patients with polymyalgia rheumatica have a vascular ultrasound assessment?
4天前
已完结
Goodbye to the term ‘ankylosing spondylitis’, hello ‘axial spondyloarthritis’: time to embrace the ASAS-defined nomenclature
4天前
已完结
Cure as a treatment target in rheumatoid arthritis and systemic sclerosis—achievable aim or mission impossible? FOREUM stimulates new industry-academia collaboration
4天前
已完结
Obesity substantially impacts rheumatic and musculoskeletal diseases: time to act
4天前
已完结
How to treat undifferentiated arthritis today or tomorrow? A consideration of treatment recommendations in light of current evidence
4天前
求助中
皖公网安备34019202002308
